Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease.

Ther Clin Risk Manag · 2018 · PMC5905495 · PMID 29695911

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The mean duration of OFF time reduced in patients receiving 260 mg (−1.3 hours) and 340 mg dose (−0.9 hours) compared with placebo, however, it did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.